Myricetin induces cell cycle arrest and suppresses tumorigenesis in bladder cancer through the interaction of EGFR-Ras and Fas signaling pathways

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Myricetin is a natural flavonol glycoside that is widely found in the fruits, bark and leaves of plant. Myricetin have been reported to possess a variety of biological activi-ties, such as antioxidant properties, anti-inflammatory effects, and antitumor activity. In this study, In this study, we demonstrated for that hyperoside inhibited the prolifer-ation of bladder cancer cells in vitro and in vivo. Moreover, hyperoside could not only induce cell cycle arrest, but also induce apoptosis in bladder cancer cells. Bioinformat-ics analysis showed that myricetin may act mainly through the EGFR-Ras and Fas sig-naling pathways. In vitro experiments showed that myricetin activated the EGFR-Ras and Fas signaling pathways, up-regulated the protein levels of EGFR, Ras and Fas. Then further activated the downstream proteins MAPK and Akt. Through the interac-tion of downstream signaling, it ultimately promotes its anticancer effects on bladder cancer cells. This study suggests that myricetin may be a promising therapeutic clinical candidate for bladder cancer.

Article activity feed